DTC Genetics Services Hit Hard on the Hill as FDA Mulls Options | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – Three consumer genomics companies caught flak on Capitol Hill yesterday from lawmakers and government witnesses at a hearing focused on direct-to-consumer genetic tests and the way they are sold and marketed — and they heard about very germ-phase plans the US Food and Drug Administration may be developing to find ways to regulate them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.